SPDR S&P Biotech ETF $XBI Shares Sold by Kassira Wealth Management LLC

Kassira Wealth Management LLC lowered its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 31.3% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 15,943 shares of the exchange traded fund’s stock after selling 7,260 shares during the period. SPDR S&P Biotech ETF comprises about 1.8% of Kassira Wealth Management LLC’s portfolio, making the stock its 19th largest holding. Kassira Wealth Management LLC’s holdings in SPDR S&P Biotech ETF were worth $1,944,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also modified their holdings of XBI. JPMorgan Chase & Co. boosted its stake in shares of SPDR S&P Biotech ETF by 27.3% in the third quarter. JPMorgan Chase & Co. now owns 13,538,738 shares of the exchange traded fund’s stock worth $1,356,582,000 after buying an additional 2,900,633 shares during the last quarter. Assetmark Inc. raised its position in SPDR S&P Biotech ETF by 1,042,265.6% during the fourth quarter. Assetmark Inc. now owns 635,843 shares of the exchange traded fund’s stock valued at $77,528,000 after acquiring an additional 635,782 shares in the last quarter. Greenwoods Asset Management Hong Kong Ltd. acquired a new position in SPDR S&P Biotech ETF in the third quarter valued at approximately $55,613,000. Ameriprise Financial Inc. lifted its holdings in SPDR S&P Biotech ETF by 123.0% in the second quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock valued at $72,542,000 after acquiring an additional 481,408 shares during the period. Finally, Meitav Investment House Ltd. boosted its position in SPDR S&P Biotech ETF by 70.3% in the 3rd quarter. Meitav Investment House Ltd. now owns 682,056 shares of the exchange traded fund’s stock worth $68,156,000 after purchasing an additional 281,602 shares in the last quarter.

SPDR S&P Biotech ETF Trading Down 2.9%

SPDR S&P Biotech ETF stock opened at $133.66 on Friday. The firm has a market cap of $8.53 billion, a PE ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a 12 month low of $75.68 and a 12 month high of $139.19. The stock’s 50 day simple moving average is $128.47 and its two-hundred day simple moving average is $123.44.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.